Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease
Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease
Recruiting · NCT06515106 · Registry updated 2024-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease | Cognition Disorders, Cognitive Dysfunction, Neuroinflammatory Diseases, brain disorder, central nervous system disorder, cognitive disorder, encephalitis, limbic encephalitis with LGI1 antibodies, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2024-07-23 | NCT06515106 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fundacion Clinic per a la Recerca Biomédica | 30 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clínic de Barcelona | Barcelona | Spain | 5 |